Brief: Ascentage Pharma Group International Files For U.S. IPO
27/12/2024 22:05
Dec 27 (Reuters) - Ascentage Pharma Group International
6855.HK :
* ASCENTAGE PHARMA GROUP INTERNATIONAL FILES FOR U.S. IPO –
SEC
FILING
* ASCENTAGE PHARMA GROUP INTERNATIONAL: APPLIED TO LIST ADSS
ON
NASDAQ, UNDER SYMBOL “AAPG"
* ASCENTAGE PHARMA GROUP INTERNATIONAL SAYS J.P. MORGAN,
CITIGROUP
ARE UNDERWRITERS TO US IPO
* ASCENTAGE PHARMA GROUP INTERNATIONAL SAYS TAKEDA
PHARMACEUTICALS
INTERNATIONAL AG BENEFICIALLY OWNED 7.7% OF ORDINARY SHARES
PRIOR TO OFFERING
Further company coverage: 6855.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ascentage Pharma International
See all newsBrief: Ascentage Pharma Group Says Lisaftoclax Granted Breakthrough Therapy Designation In China
China's Ascentage Pharma climbs as chairman buys shares on market
Brief: Ascentage Pharma Group International's Chairman Buys 38,630 Shares
Brief: Ascentage Pharma Group International Posts H1 Net Loss Attributable RMB816.7 Million
China's Ascentage Pharma H1 revenue rises 29% on Lisaftoclax ramp-up